Bipolar Disorder

The data assess the extended efficacy of the treatment for up to 4 years.

OABD is a significant concern among older adults, characterized by unique presentations and comorbidities. Here's what you need to know.

What is new in research on ADHD?

What is new in research on bipolar disorder?

Here are some updates from the world of psychiatry throughout the month of October.

What are some key considerations in diagnosing bipolar disorder? Joseph F. Goldberg, MD, shares insights at the recent 2023 Annual Psychiatric Times World CME Conference.

This study is the first to assess the efficacy of this drug combination in a real-world setting.

Get ready for our upcoming virtual, interactive conference with some highlights from 2022.

From violence risk assessment in emergency departments to connections between bipolar disorder and substance use disorders, here are highlights from the week in Psychiatric Times.

An expert discusses the connections between the 2 highly comorbid diseases and some ways to effectively treat both diseases simultaneously.

What is new in research on transcranial magnetic stimulation?

One professional psychiatrist shares his account of living with bipolar affective disorder.

For one patient, the road to wellness was also a creative journey.

How does a patient process their illness and move their way to healing and even creativity?

This book could be a resource for your patients with bipolar disorder…

From research updates on at-home ketamine use to the effects of comorbid depression and anxiety on insomnia treatment, here are highlights from the week in Psychiatric Times.

Gestational and neonatal risk factors for bipolar disorder? Researchers investigated these associations in a nationwide cohort with register-based data.

Neuroimaging could help predict clinical response to treatment in bipolar depression.

PME affects many women, yet it remains under-recognized in clinical practice and in research.

In Part III of this series, an expert discusses the key differences between cyclothymia and borderline personality disorder, along with treatment considerations for cyclothymia.

In Part II of this series, an expert discusses cyclothymia and mood temperament in children and adolescents.

In Part I of this new series, an expert provides an overview of cyclothymia and mood temperaments.

A look at the theme for the 2023 American Psychiatric Association Annual Meeting.

From connections between bvFTD and primary psychiatric disorders to the impact of posttraumatic neuroendocrine dysfunction on recovery, here are highlights from the week in Psychiatric Times.

Aripiprazole will be the first 2-month LAI antipsychotic indicated for both the treatment of schizophrenia and the maintenance treatment of bipolar I disorder in the United States.

From to co-occurring substance use and eating disorders to treatment options for OCD, here are highlights from the week in Psychiatric Times.

What is the current role of lithium?

From gut microbiota and SSRIs in MDD to nonpharmacological interventions following TBI, here are highlights from the week in Psychiatric Times.

The experts weighed in on a wide variety of psychiatric issues for the March 2023 issue of Psychiatric Times.

March 30 is World Bipolar Day, a day dedicated to raising awareness and eliminating stigma surrounding bipolar disorders. Learn more about bipolar disorders by catching up on the latest bipolar research in Psychiatric Times®.